Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1357 | 2017 |
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 942 | 2019 |
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer FJ Couch, SN Hart, P Sharma, AE Toland, X Wang, P Miron, JE Olson, ... Journal of clinical oncology 33 (4), 304-311, 2015 | 735 | 2015 |
Associations between cancer predisposition testing panel genes and breast cancer FJ Couch, H Shimelis, C Hu, SN Hart, EC Polley, J Na, E Hallberg, ... JAMA oncology 3 (9), 1190-1196, 2017 | 631 | 2017 |
A population-based study of genes previously implicated in breast cancer C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ... New England Journal of Medicine 384 (5), 440-451, 2021 | 609 | 2021 |
Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer C Hu, SN Hart, EC Polley, R Gnanaolivu, H Shimelis, KY Lee, J Lilyquist, ... Jama 319 (23), 2401-2409, 2018 | 508 | 2018 |
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 362 | 2017 |
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues SN Hart, Y Li, K Nakamoto, E Subileau, D Steen, X Zhong Drug metabolism and disposition 38 (6), 988-994, 2010 | 321 | 2010 |
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma RP Graham, EGB Fritcher, E Pestova, J Schulz, LA Sitailo, G Vasmatzis, ... Human pathology 45 (8), 1630-1638, 2014 | 319 | 2014 |
Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 310 | 2015 |
Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing H Shimelis, H LaDuca, C Hu, SN Hart, J Na, A Thomas, M Akinhanmi, ... JNCI: Journal of the National Cancer Institute 110 (8), 855-862, 2018 | 308 | 2018 |
Calculating sample size estimates for RNA sequencing data SN Hart, TM Therneau, Y Zhang, GA Poland, JP Kocher Journal of computational biology 20 (12), 970-978, 2013 | 296 | 2013 |
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor SJ Murphy, SN Hart, JF Lima, BR Kipp, M Klebig, JL Winters, C Szabo, ... Gastroenterology 145 (5), 1098-1109. e1, 2013 | 225 | 2013 |
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer JI Kiiski, LM Pelttari, S Khan, ES Freysteinsdottir, I Reynisdottir, SN Hart, ... Proceedings of the National Academy of Sciences 111 (42), 15172-15177, 2014 | 222 | 2014 |
Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine AM Thomas, SN Hart, B Kong, J Fang, X Zhong, GL Guo Hepatology 51 (4), 1410-1419, 2010 | 211 | 2010 |
Bioinformatics for clinical next generation sequencing GR Oliver, SN Hart, EW Klee Clinical chemistry 61 (1), 124-135, 2015 | 193 | 2015 |
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high … H LaDuca, EC Polley, A Yussuf, L Hoang, S Gutierrez, SN Hart, S Yadav, ... Genetics in Medicine 22 (2), 407-415, 2020 | 185 | 2020 |
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma B Leonard, SN Hart, MB Burns, MA Carpenter, NA Temiz, A Rathore, ... Cancer research 73 (24), 7222-7231, 2013 | 181 | 2013 |
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls J Lilyquist, H LaDuca, E Polley, BT Davis, H Shimelis, C Hu, SN Hart, ... Gynecologic oncology 147 (2), 375-380, 2017 | 153 | 2017 |